期刊文献+

DFMO通过Fas/FasL通路诱导人肺癌细胞凋亡的研究 被引量:1

Apoptotic Induction of Human Lung Carcinoma A549 Cells by DFMO through Fas/FasL Pathway
下载PDF
导出
摘要 背景与目的:Fas/FasL系统是细胞凋亡的重要通路。为了解Fas/FasL系统在肿瘤多胺生物合成抑制导致恶性表型逆转中的作用,本研究拟探讨多胺生物合成抑制剂α-二氟甲基鸟氨酸(α-difluoromethylornithine,DFMO)对人肺癌A549细胞生长、凋亡的影响及其与人肺癌相关抗原、rasP21蛋白及Fas/FasL表达的相关性。方法:用MTT法观察细胞生长,流式细胞仪分析细胞周期,DNAladder电泳法观察细胞凋亡,SP免疫组化法及RT-PCR法检测细胞蛋白及基因表达。结果:DFMO可抑制A549细胞生长并诱导凋亡,使G1期细胞增多(61.0±2.08)%,S期细胞减少(21.2±0.88)%,出现DNAladder;同时下调A549细胞人肺癌相关抗原及rasP21蛋白表达,上调Fas基因mRNA及蛋白表达。结论:DFMO通过Fas/FasL通路诱导肺癌A549细胞的凋亡,并可能与人肺癌相关抗原及rasP21蛋白表达调控有关。 BACKGROUND &OBJECTIVE: Fas/FasL pathway play an important role in cell apoptosis. To investigate the role of Fas/FasL system in polyamine biosyth esis inhibition and malignant phenotype reversion of carcinoma cells, we examine d the effect of DFMO (α-difluoromethylornithine), an inhibitor of polyamine bi osynthesis, on cell growth and apoptosis of A549 cells, and their association wi th human lung carcinoma-associated antigen, ras P21 protein, and Fas/FasL. METH ODS: MTT assay,flow cytometry,and DNA fragmentation analysis were used to determ ine cell growth and apoptosis,respectively.The gene and protein expression were determined by reverse transcription polymerase chain reaction (RT-PCR) and immu nohistochemical staining, respectively. RESULTS: DFMO could inhibit the growth o f A549 cells and induce their apoptosis, meanwhile the cells in G1 phase were in creased with (61.0±2.08)%, the cells in S phase were decreased with (21.2±0.8 8)%, and DNA ladder were observed. Simultaneously, the expression of human lung carcinoma-associated antigen and ras P21 protein were downregulated, but Fas m RNA and protein expression were upregulated. CONCLUSION: DFMO induce apoptosis o f human lung carcinoma A549 cells through Fas/FasL pathway. It might be correlat ed with the expression of human lung carcinoma-associated antigen and ras P21 p rotein.
出处 《癌症》 SCIE CAS CSCD 北大核心 2003年第12期1260-1263,共4页 Chinese Journal of Cancer
关键词 DFMO FAS FasL通路 诱导 肺癌 细胞凋亡 Lung carcinoma Human Fas/FasL system Polyamines Apoptosis
  • 相关文献

参考文献4

二级参考文献12

  • 1吴克斌,范慕贞.抗多胺代谢与HL-60细胞c-myc、c-fos、c-Ha-ras及ODC基因的表达[J].中日友好医院学报,1992,6(S1):224-226. 被引量:8
  • 2[1]Nagata S. Apoptosis by death factor[J]. Cell, 1997,88:355-356.
  • 3[2]Gruss H J, Dower S.Tumor necrosis factor ligand superfamily: nvolvement in the pathology of malignant lymphoma[J]. Blood,1995,85:3378-3404.
  • 4[3]Cathevine G, Yasuo T. Christoph B, et al. Up-Regulation of Fas (APO-1/CD95)Ligand and Down-Regulation of Fas Expression in Human Esophageal Cance[J]. Cancer Research, 1998,58:2057.
  • 5[4]Susanne S, Water J, Hofmann, et al. Lymphocyte apoptosis induced by CD95(APO-1/Fas)ligand-expressing tumor cells-A mechanism of immune evasion[J].Nature Medicine, 1996, 2:1361.
  • 6[5]Hickman JA. Apoptosis induced by anticancer drugs[J]. Cancer Metastasis Rev, 1992, 11:121-139.
  • 7[6]Rokhlin, O W, Bishop, GA, Hostager, BS, et al. Fas-mediated apoptosis in human prostatic carcinoma cell lines[J]. Cancer Res,1997, 57:758-1768.
  • 8[7]Owen-Schaub LB, R Krunzel,Radinsky, E, et al. Anti-Fas on nonhematopoietic tumor: levels of Fas/Apo-1 and bcl-2are not predictive of biological responsiveness[J]. Cancer Res, 1994,54:1580-1586.
  • 9[8]Shunai J, Moon JS, Eui-Cheol S, et al. Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fas-independent pathways[J]. Hepatology, 1999,29:1.
  • 10[9]Thompson, CB. Apoptosis in pathogenesis and treatment of diease[J]. Science, 1995, 267:1456-1461.

共引文献10

同被引文献12

  • 1[1]Kelland LR.Flavopiridol,the first cyclin-dependent kinase inhibitor to enter the clinic:current status.Expert Opin Investig Drugs,2000,9:2903-2911.
  • 2[2]Vlastos AT,West LA,Atkinson EN,et al.Results of a phase Ⅱ double-blinded randomized clinical trial of difluoromethylornithine for cervical intraepithelial neoplasia grades 2 to 3.Clin Cancer Res,2005,11:390-396.
  • 3[4]Zou CP,Vlastos AT,Li Y,et al.Effects of difluoromethylornithine on growth inhibition and apoptosis in human cervical epithelial and cancerous cell lines.Gynecol Oncol,2002,85:266-273.
  • 4[6]Cheung TH,Yu MM,Lo KW,et al.Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix.Cancer Lett,2001,166:199-206.
  • 5[7]Clarke B,Chetty R.Cell cycle aberrations in the pathogenesis of squamous cell carcinoma of the uterine cervix.Gynecol Oncol,2001,82:238-246.
  • 6[9]Boiko IV,Mitchell M,Hu W.Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an alpha-difluoromethylornithine chemoprevention trial.Clin Cancer Res,1998,4:1383-1391.
  • 7[11]Wallick CJ,Gamper I,Thorne M,et al.Key role for p27Kip1,retinoblastoma protein Rb,and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells.Oncogene,2005,24:5606-5618.
  • 8[12]Broaddus RR,Xie S,Hsu CJ,et al.The chemopreventive agents 4-HPR and DFMO inhibit growth and induce apoptosis in uterine leiomyomas.Am J Obstet Gynecol,2004,190:686-692.
  • 9[14]Obaya J,Sedivy JM.Regulation of cyclin-CPK activity in mammalian cells.Cell Mol Life Sci,2002,59:126-142.
  • 10[15]Fong LY,Feith DJ,Pegg AE.Antizyme overexpression in transgenic mice reduces cell proliferation,increases apoptosis,and reduces N-nitrosomethylbenzylamine-induced forestomach carcinogenesis.Cancer Res,2003,63:3945-3954.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部